부산대학교 도서관

French J; New York University, Langone Health, New York, New York, USA.; Biton V; Arkansas Epilepsy Program, Little Rock, Arkansas, USA.; Dave H; University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Detyniecki K; University of Miami, Coral Gables, Florida, USA.; Gelfand MA; University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Gong H; Rancho Los Amigos National Rehabilitation Center, Downey, California, USA.; Liow K; Hawaii Pacific Neuroscience, Honolulu, Hawaii, USA.; O'Brien TJ; Monash University and Alfred Hospital, Melbourne, Australia.; Sadek A; Research Institute of Orlando, LLC, Orlando, Florida, USA.; DiVentura B; The Epilepsy Study Consortium, Woodbury, New Jersey, USA.; Reich B; Engage Therapeutics, Inc., Summit, New Jersey, USA.; Isojarvi J; Engage Therapeutics, Inc., Summit, New Jersey, USA.

Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE

Steriade C; New York University Comprehensive Epilepsy Center, New York, New York, USA.; Epilepsy Study Consortium, Reston, Virginia, USA.; Sperling MR; Epilepsy Study Consortium, Reston, Virginia, USA.; Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; DiVentura B; Epilepsy Study Consortium, Reston, Virginia, USA.; Lozano M; Epilepsy Study Consortium, Reston, Virginia, USA.; Shellhaas RA; Epilepsy Study Consortium, Reston, Virginia, USA.; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.; Kessler SK; Epilepsy Study Consortium, Reston, Virginia, USA.; Departments of Neurology and Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Dlugos D; Epilepsy Study Consortium, Reston, Virginia, USA.; Departments of Neurology and Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; French J; New York University Comprehensive Epilepsy Center, New York, New York, USA.; Epilepsy Study Consortium, Reston, Virginia, USA.

Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE

Gurrell R; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID. Rachel.Gurrell@Pfizer.com.; Gorman D; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Whitlock M; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Ogden A; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Reynolds DS; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; DiVentura B; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Abou-Khalil B; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Gelfand M; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Pollard J; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Hogan RE; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Krauss G; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Sperling M; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Vazquez B; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Wechsler RT; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Friedman D; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; Butt RP; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.; French J; From Pfizer Inc. (R.G., D.G., M.W., D.S.R., R.P.B.), Cambridge, UK; Pfizer Inc. (A.O.), Groton, CT; The Epilepsy Study Consortium (B.D.), Reston, VA; Department of Neurology (B.A.-K.), Vanderbilt University Medical Center, Nashville, TN; University of Pennsylvania (M.G., J.P.), Philadelphia; Washington University in St. Louis (R.E.H.), MO; Johns Hopkins Hospital (G.K.), Baltimore, MD; Thomas Jefferson University (M.S.), Philadelphia, PA; Comprehensive Epilepsy Center (B.V., D.F., J.F.), Department of Neurology, New York University, New York; and Consultants in Epilepsy and Neurology PLLC (R.T.W.), Boise, ID.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

Masanet, Maria-Jose; Ventura, Rafael; Ballesté, Eduard

Social Inclusion, 10, 2, 143-155, Promoting Social Inclusive Experiences in Uncertain Times

Gurrell, R.; Gorman, D.; Whitlock, M.; Ogden, A.; Reynolds, D. S.; DiVentura, B.; Abou-Khalil, B.; Gelfand, M.; Pollard, J.; Hogan, R. E.; Krauss, G.; Sperling, M.; Vazquez, B.; Wechsler, R. T.; Friedman, D.; Butt, R. P.; French, J.

EPILEPSIA; NOV 2019, 60 p65-p65, 1p. Supplement: 2

French JA; Krauss GL; Wechsler RT; Wang XF; DiVentura B; Brandt C; Trinka E; O'Brien TJ; Laurenza A; Patten A; Bibbiani F

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

Kasteleijn-Nolst Trenité DG; Department of Medical Genetics, Utrecht University, Utrecht, The Netherlands. dkasteleijn@planet.nl; Biton V; French JA; Abou-Khalil B; Rosenfeld WE; Diventura B; Moore EL; Hetherington SV; Rigdon GC

Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE

Hesdorffer DC; GH Sergievsky Center and Department of Epidemiology, Columbia University, New York, New York 10032, USA. dch5@columbia.edu; French JA; Posner K; DiVentura B; Pollard JR; Sperling MR; Harden CL; Krauss GL; Kanner AM

Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE

Fisher RS; Stanford University, Department of Neurology and Neurological Sciences, Stanford, CA 94305‐5235, USA. robert.fisher@stanford.edu; Blum DE; DiVentura B; Vannest J; Hixson JD; Moss R; Herman ST; Fureman BE; French JA

Publisher: Academic Press Country of Publication: United States NLM ID: 100892858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-5069 (Electronic) Linking ISSN: 15255050 NLM ISO Abbreviation: Epilepsy Behav Subsets: MEDLINE

French, J. A.; Diventura, B.; Trinka, E.; Bibbiani, F.; Yang, H.

EPILEPSIA; FEB 2015, 56 p13-p13, 1p. Supplement: 1